Aquipta vs Vydura: Side-by-Side Comparison
Quick answer: Aquipta and Vydura are both cgrp receptor antagonist (gepant) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Aquipta | Vydura |
|---|---|---|
| Drug class | CGRP receptor antagonist (gepant) | CGRP receptor antagonist (gepant) |
| ATC code | N02CD | N02CD06 |
| Primary indications | Preventive treatment of episodic and chronic migraine | Acute treatment of migraine, Preventive treatment of episodic migraine |
| Mechanism | Small-molecule antagonist of calcitonin gene-related peptide (CGRP) receptor | Rimegepant is a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist blocking CGRP-mediated trigeminovascular signaling. |
| Common dose | 60 mg once daily | 75 mg orally disintegrating tablet as needed (max once daily) or every other day for prevention |
| Detail page | Aquipta details → | Vydura details → |
How to choose between Aquipta and Vydura
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All CGRP receptor antagonist (gepant) on iMedic · Aquipta full details · Vydura full details
Frequently asked questions
Is Aquipta better than Vydura?
Neither is universally 'better.' They are both cgrp receptor antagonist (gepant) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Aquipta to Vydura?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Aquipta and Vydura have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Aquipta and Vydura available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.